Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carine Van Lint

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Virologie (Montrouge, France)|August 16, 2019
[Viral latency of HIV-1]Sophie Bouchat, Carine Van Lint
Biochemical Pharmacology|September 6, 2002
Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model systemVincent Quivy, Carine Van Lint
Retrovirology|December 8, 2009
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategiesLaurence Colin, Carine Van Lint
Current Opinion in HIV and AIDS|November 20, 2025
Latency-reversing agents: where are we now?Maryam Bendoumou, Carine Van Lint
Biochemical Pharmacology|August 18, 2004
Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylationVincent Quivy, Carine Van Lint
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2013
HIV-1 chromatin, transcription, and the regulatory protein TatLaurence Colin, Eric Verdin, Carine Van Lint
Retrovirology|June 28, 2013
HIV-1 transcription and latency: an updateCarine Van Lint, Sophie Bouchat, Alessandro Marcello
Vaccines|June 2, 2021
Epigenetic Mechanisms of HIV-1 PersistenceRoxane Verdikt, Olivier Hernalsteens, Carine Van Lint
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral LatencyAnthony Rodari, Guido Poli, Carine Van Lint
Retrovirology|June 2, 2023
A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulationEstelle Plant, Maxime Bellefroid, Carine Van Lint
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Virologie (Montrouge, France)|August 16, 2019
[Viral latency of HIV-1]Sophie Bouchat, Carine Van Lint
Biochemical Pharmacology|September 6, 2002
Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model systemVincent Quivy, Carine Van Lint
Retrovirology|December 8, 2009
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategiesLaurence Colin, Carine Van Lint
Current Opinion in HIV and AIDS|November 20, 2025
Latency-reversing agents: where are we now?Maryam Bendoumou, Carine Van Lint
Biochemical Pharmacology|August 18, 2004
Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylationVincent Quivy, Carine Van Lint
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2013
HIV-1 chromatin, transcription, and the regulatory protein TatLaurence Colin, Eric Verdin, Carine Van Lint
Retrovirology|June 28, 2013
HIV-1 transcription and latency: an updateCarine Van Lint, Sophie Bouchat, Alessandro Marcello
Vaccines|June 2, 2021
Epigenetic Mechanisms of HIV-1 PersistenceRoxane Verdikt, Olivier Hernalsteens, Carine Van Lint
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral LatencyAnthony Rodari, Guido Poli, Carine Van Lint
Retrovirology|June 2, 2023
A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulationEstelle Plant, Maxime Bellefroid, Carine Van Lint
Pageof 12